Literature DB >> 2421633

Protein and RNA turnover in preterm infants and adults: a comparison based on urinary excretion of 3-methylhistidine and of modified one-way RNA catabolites.

G Sander, J Hülsemann, H Topp, G Heller-Schöch, G Schöch.   

Abstract

Urinary excretion of 3-methylhistidine in preterm infants (n = 42; 1,712 +/- 408 g, 4-91 days old) was 24.2 +/- 6 mumol/mmol creatinine or 2.26 +/- 0.56 mumol/kg body weight X day. In adults (n = 6; 66 +/- 10 kg, 17-50 years), the corresponding values were 10.5 +/- 1.1 mumol/mmol creatinine and 2.21 +/- 0.23 mumol/kg body weight X day. For both collectives, the breakdown per kg body weight of 3-methylhistidine-containing protein (i.e. actin and myosin) was similar, at approximately 0.7 g/kg X day (preterm infants 0.84, adults 0.60). Since the preterm infants studied contain approximately 21% muscle instead of the 43% found in adults, the 3-methylhistidine excretion in preterm infants probably indicates muscle (and intestinal) protein turnover to be about 3 times higher than in adults, a figure in accord with data on whole-body protein turnover in preterm infants and adults (approximately 15 g/kg X day and approximately 4 g/kg X day, respectively). Urinary excretion of pseudouridine (psi), 7-methylguanine (m7Gua) and N2, N2-dimethylguanosine (m2(2)G) can be used to estimate the turnover of rRNA, mRNA and tRNA, respectively. The values obtained (in mumol/mmol creatinine) in preterm infants are for psi: 164 +/- 32; for m7Gua: 39.1 +/- 9; and for m2(2)G: 10.6 +/- 2.1. In adults, the values are for psi: 25.3 +/- 3.1; for m7Gua: 4.8 +/- 0.89; and for m2(2)G: 1.53 +/- 0.38. This yields 3-4 times higher turnover rates in preterm infants than in adults for all 3 RNA classes: rRNA, 0.1 versus 0.038; tRNA, 1.87 versus 0.66; mRNA 2.35 versus 0.64 mumol/kg X day.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 2421633     DOI: 10.1159/000177186

Source DB:  PubMed          Journal:  Ann Nutr Metab        ISSN: 0250-6807            Impact factor:   3.374


  7 in total

1.  Urinary nucleosides as biological markers for patients with colorectal cancer.

Authors:  Yu-Fang Zheng; Jun Yang; Xin-Jie Zhao; Bo Feng; Hong-Wei Kong; Ying-Jie Chen; Shen Lv; Min-Hua Zheng; Guo-Wang Xu
Journal:  World J Gastroenterol       Date:  2005-07-07       Impact factor: 5.742

2.  Serum Compounds of Energy Metabolism Impairment Are Related to Disability, Disease Course and Neuroimaging in Multiple Sclerosis.

Authors:  Giacomo Lazzarino; Angela M Amorini; Axel Petzold; Claudio Gasperini; Serena Ruggieri; Maria Esmeralda Quartuccio; Giuseppe Lazzarino; Enrico Di Stasio; Barbara Tavazzi
Journal:  Mol Neurobiol       Date:  2016-11-08       Impact factor: 5.590

3.  Phenylalanine and other amino acids in phenylketonuria.

Authors:  P C Clemens; J G Burmester; B H Prankel; G Wiegand; A P Wulke; C Plettner
Journal:  J Inherit Metab Dis       Date:  1993       Impact factor: 4.982

4.  Modulation of circulating purines and pyrimidines by physical exercise in the horse.

Authors:  Daniela Alberghina; Giuseppe Piccione; Angela Maria Amorini; Serafina D'Urso; Salvatore Longo; Marika Picardi; Barbara Tavazzi; Giuseppe Lazzarino
Journal:  Eur J Appl Physiol       Date:  2010-10-08       Impact factor: 3.078

5.  Toxicological Properties of 7-Methylguanine, and Preliminary Data on its Anticancer Activity.

Authors:  Kirill Kirsanov; Timur Fetisov; Elena Antoshina; Lubov Trukhanova; Tatiana Gor'kova; Olga Vlasova; Irina Khitrovo; Ekaterina Lesovaya; Nataliya Kulbachevskaya; Tatiana Shcherbakova; Gennady Belitsky; Marianna Yakubovskaya; Vytas Švedas; Dmitry Nilov
Journal:  Front Pharmacol       Date:  2022-07-06       Impact factor: 5.988

6.  Ribonucleosides as minor milk constituents.

Authors:  E Schlimme; K P Raezke; F G Ott
Journal:  Z Ernahrungswiss       Date:  1991-06

7.  Serum metabolic profile in multiple sclerosis patients.

Authors:  Barbara Tavazzi; Anna Paola Batocchi; Angela Maria Amorini; Viviana Nociti; Serafina D'Urso; Salvatore Longo; Stefano Gullotta; Marika Picardi; Giuseppe Lazzarino
Journal:  Mult Scler Int       Date:  2011-06-28
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.